Successful Early Lamotrigine and Aripiprazole Augmentation of Clomipramine in Severe Obsessive-compulsive Disorder
Clinical Psychopharmacology and Neuroscience
;
: 604-608, 2023.
Article
in English
| WPRIM
| ID: wpr-1000093
ABSTRACT
Lamotrigine and aripiprazole have shown efficacy as augmentation agents of serotonin reuptake inhibitors for treatment-resistant obsessive-compulsive disorder (OCD). To date, the efficacy of lamotrigine/aripiprazole augmentation has not been reported in OCD treatment. Herein, we report the case of a 37-year-old male with severe OCD and comorbid depression whose symptoms markedly improved after low-dose lamotrigine/aripiprazole augmentation to clomipramine.Our report suggests that early glutamatergic/antipsychotic augmentation contributes to rapid remission of OCD symptoms.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
English
Journal:
Clinical Psychopharmacology and Neuroscience
Year:
2023
Type:
Article
Similar
MEDLINE
...
LILACS
LIS